PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery.
Hiroshi NakagomiMasayuki InoueYosuke HirotsuKenji AmemiyaHitoshi MochidukiMasao OmataPublished in: Breast cancer research and treatment (2022)
Genome profiling revealed that abnormalities in the PIK3CA-AKT pathway in long-term residential recurrences and are a crucial molecular group in the development of IBTR.